Back to AG Adage Capital Partners GP, L.L.C.
ACRS
Showing 7 of 26 quarters
Position history for AGAdage Capital Partners GP, L.L.C.'s holdings in Aclaris Therapeutics, Inc.
Yes. Adage Capital Partners GP holds 4,071,000 shares of ACRS (Aclaris Therapeutics), worth $21.5M, as of its Q2 2026 13F filing. It increased the position by 200,000 shares (+5.2%) from Q1 2026. Adage Capital Partners GP has held ACRS since Q4 2024, across 7 quarterly 13F filings.
Current Value
$21.5M
Current Shares
4.1M
Total Value Change
-$2.3M
Total Shares Change
-5.6M
Quarter-by-Quarter History